Simon Tazzyman

3.5k total citations · 2 hit papers
25 papers, 2.2k citations indexed

About

Simon Tazzyman is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Simon Tazzyman has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Immunology. Recurrent topics in Simon Tazzyman's work include Virus-based gene therapy research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Immune cells in cancer (4 papers). Simon Tazzyman is often cited by papers focused on Virus-based gene therapy research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Immune cells in cancer (4 papers). Simon Tazzyman collaborates with scholars based in United Kingdom, United States and Switzerland. Simon Tazzyman's co-authors include Claire E. Lewis, Craig Murdoch, Russell Hughes, Steve J. Webster, Nicola J. Brown, Carolyn A. Staton, Michele De Palma, Ioanna Keklikoglou, Jeffrey W. Pollard and Stephen M. Stribbling and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Simon Tazzyman

25 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

2018 414 citations Ioanna Keklikoglou, Chiara Cianciaruso et al. Nature Cell Biology profile →
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

2015 399 citations Russell Hughes, Bin‐Zhi Qian et al. Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Simon Tazzyman	999	716	621	478	358	25	2.2k
María Virtudes Céspedes	1.2k 1.2×	387 0.5×	704 1.1×	358 0.7×	163 0.5×	65	2.2k
Chiara Brignole	1.4k 1.4×	642 0.9×	494 0.8×	423 0.9×	397 1.1×	55	2.7k
Danilo Marimpietri	1.5k 1.5×	412 0.6×	578 0.9×	459 1.0×	293 0.8×	67	2.6k
Xiao Zhao	1.3k 1.3×	413 0.6×	471 0.8×	587 1.2×	533 1.5×	53	2.7k
Jingwei Ma	1.7k 1.7×	1.1k 1.5×	565 0.9×	807 1.7×	466 1.3×	63	3.1k
Santiago Rello‐Varona	872 0.9×	575 0.8×	614 1.0×	230 0.5×	305 0.9×	32	2.1k
Brigitte Mack	1.5k 1.5×	772 1.1×	1.4k 2.2×	656 1.4×	249 0.7×	70	3.2k
Carsten Weishaupt	948 0.9×	863 1.2×	1.3k 2.2×	327 0.7×	145 0.4×	61	2.6k
Curtis B. Thompson	1.3k 1.3×	430 0.6×	1.1k 1.8×	372 0.8×	281 0.8×	51	2.6k
Luis Álvarez‐Vallina	1.5k 1.5×	785 1.1×	1.2k 2.0×	191 0.4×	341 1.0×	93	2.9k

Countries citing papers authored by Simon Tazzyman

Since Specialization

Citations

This map shows the geographic impact of Simon Tazzyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Tazzyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Tazzyman more than expected).

Fields of papers citing papers by Simon Tazzyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Tazzyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Tazzyman. The network helps show where Simon Tazzyman may publish in the future.

Co-authorship network of co-authors of Simon Tazzyman

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Tazzyman. A scholar is included among the top collaborators of Simon Tazzyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Tazzyman. Simon Tazzyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tazzyman, Simon, Darren Lath, Joe Conner, et al.. (2023). HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models. Viruses. 15(3). 603–603. 4 indexed citations

Dorris, Emma, Simon Tazzyman, Nandhini Ramamoorthi, et al.. (2019). The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation. The Journal of Immunology. 202(4). 1069–1078. 11 indexed citations

Keklikoglou, Ioanna, Chiara Cianciaruso, Esra Güç, et al.. (2018). Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nature Cell Biology. 21(2). 190–202. 414 indexed citations breakdown →

Paton‐Hough, Julia, Simon Tazzyman, Holly Evans, et al.. (2018). Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models. Journal of Bone and Mineral Research. 34(5). 783–796. 16 indexed citations

Tazzyman, Simon, Darren Lath, Jenny Down, et al.. (2018). Myeloma-Specific Oncolytic Adenovirus Induces Significant Tumour Oncolysis In Vitro and In Vivo and Prevents Cell Line Regrowth. Blood. 132(Supplement 1). 3213–3213. 2 indexed citations

Brown, Hannah K., et al.. (2017). Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opinion on Drug Discovery. 12(4). 379–389. 90 indexed citations

Hughes, Russell, Bin‐Zhi Qian, Charlotte Rowan, et al.. (2015). Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. Cancer Research. 75(17). 3479–3491. 399 indexed citations breakdown →

Tazzyman, Simon, Amy Evans, Iveta Garaiová, et al.. (2015). Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial. BMJ Open Gastroenterology. 2(1). e000052–e000052. 39 indexed citations

Tazzyman, Simon, et al.. (2015). Development of a Trojan horse oncolytic virus for treatment of myeloma.. Journal of Clinical Oncology. 33(15_suppl). e14035–e14035. 3 indexed citations

10.

Gray, Caroline, D Bratt, Marc Da Costa, et al.. (2013). Loss of Function of Parathyroid Hormone Receptor 1 Induces Notch-Dependent Aortic Defects During Zebrafish Vascular Development. Arteriosclerosis Thrombosis and Vascular Biology. 33(6). 1257–1263. 11 indexed citations

11.

Muthana, Munitta, Yung‐Yi Chen, Abigail Welford, et al.. (2012). Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation. Cancer Research. 73(2). 490–495. 86 indexed citations

12.

Tazzyman, Simon, Simon T. Barry, Susan Ashton, et al.. (2011). Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2‐specific antagonist is associated with reduced tumor growth. International Journal of Cancer. 129(4). 847–858. 89 indexed citations

13.

Lewis, Claire E., et al.. (2010). A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo. British Journal of Cancer. 102(3). 594–601. 13 indexed citations

14.

Ryan, Rachel, Patrick J. Williams, Simon Tazzyman, et al.. (2009). Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Therapy. 16(3). 329–339. 143 indexed citations

15.

Tazzyman, Simon, Eva Løbner Lund, Nanna Junker, et al.. (2008). Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner. Cancer Letters. 265(2). 239–249. 32 indexed citations

16.

Staton, C A, Stephen M. Stribbling, Carlos Garcı́a-Echeverrı́a, et al.. (2007). Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin. Journal of Thrombosis and Haemostasis. 5(4). 846–854. 12 indexed citations

17.

Murdoch, Craig, Simon Tazzyman, Steve J. Webster, & Claire E. Lewis. (2007). Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2. The Journal of Immunology. 178(11). 7405–7411. 250 indexed citations

18.

Staton, Carolyn A., Stephen M. Stribbling, Simon Tazzyman, et al.. (2004). Current methods for assaying angiogenesisin vitroandin vivo. International Journal of Experimental Pathology. 85(5). 233–248. 266 indexed citations

19.

Staton, Carolyn A., Nicola J. Brown, Kevin P. Corke, et al.. (2003). Alphastatin, a 24–amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood. 103(2). 601–606. 49 indexed citations

20.

Tazzyman, Simon, et al.. (2001). Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis. 4(4). 269–275. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact